Using IVR to Maintain ACS Patients on Best Practice Guidelines
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 654 participants.
Also called NCT01260207
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 654 participants
- Sponsor
- Registry
-
NCT01260207
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Terminated
Technical summary
Registry record NCT01260207. Randomized; single masking; primary purpose treatment. Start 2010-01 (actual); primary completion 2014-12-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Using IVR to Maintain ACS Patients on Best Practice Guidelines
- Acronym
- IVR-ACS BPG
- Condition
- Acute Coronary Syndrome
- Condition
- Medication Adherence
- Intervention (Other)
- IVR group
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Collaborator
- Ottawa Heart Institute Research Corporation
Record details
- Record id
cardio:ct-nct01260207- Content hash
8f1605a4836395363af3f96f57ad096e6a52e66af9065de0596e5b6e345e0acf